Tips, announcements, corrections and partnerships.
Email the newsroom at news@charted.news. We read every message.
Closing a round, an acquisition, or an FDA decision? Send the announcement and any supporting filing. We report from documents, so a press release, Form D, 8-K or FDA decision letter speeds things up. Mark embargoed material clearly with the embargo time in the subject line.
Spotted an error? See our corrections policy, or email the article URL, the issue, and a document that shows the correct fact.
Email the address above with "Partnerships" in the subject line.
The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.